ArticlePloS one2017

In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.

Jianxun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.